- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Acuson moves NHTI to 128XP line
Acuson of Mountain View, CA, has migrated its Native Tissue Harmonic Imaging technique to its 128XP ultrasound scanners. NTHI was first introduced on the super-premium Sequoia system last year. Since then it has been moved to other systems in the
Acuson of Mountain View, CA, has migrated its Native Tissue Harmonic Imaging technique to its 128XP ultrasound scanners. NTHI was first introduced on the super-premium Sequoia system last year. Since then it has been moved to other systems in the companys product line, such as Aspen and 128XP. The upgrade will begin shipping next year and will be available to all 128XP users.
In other Acuson news, the company landed a preferred provider contract with Columbia/HCA, which named Acuson as one of three ultrasound providers to the hospital chain. The deal extends an existing relationship between Acuson and Columbia. Acuson estimated that the agreement will be worth about $15 million over the next two years.
Can Generative AI Facilitate Simulated Contrast Enhancement for Prostate MRI?
January 14th 2025Deep learning synthesis of contrast-enhanced MRI from non-contrast prostate MRI sequences provided an average multiscale structural similarity index of 70 percent with actual contrast-enhanced prostate MRI in external validation testing from newly published research.
Can MRI Have an Impact with Fertility-Sparing Treatments for Endometrial and Cervical Cancers?
January 9th 2025In a literature review that includes insights from recently issued guidelines from multiple European medical societies, researchers discuss the role of magnetic resonance imaging (MRI) in facilitating appropriate patient selection for fertility-sparing treatments to address early-stage endometrial and cervical cancer.
